Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Class A 600329

Morningstar Rating
¥35.50 +3.23 (10.01%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

600329 is trading at a 819% premium.
Price
¥32.43
Fair Value
¥78.58
Uncertainty
High
1-Star Price
¥44.88
5-Star Price
¥13.13
Economic Moat
Lhftt
Capital Allocation

News

Trading Information

Previous Close Price
¥32.27
Day Range
¥33.5135.50
52-Week Range
¥23.4038.04
Bid/Ask
¥35.50 / ¥0.00
Market Cap
¥27.34 Bil
Volume/Avg
14.7 Mil / 4.8 Mil

Key Statistics

Price/Earnings (Normalized)
28.24
Price/Sales
3.08
Dividend Yield (Trailing)
3.97%
Dividend Yield (Forward)
3.97%
Total Yield
3.97%

Company Profile

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Value
Total Number of Employees
4,619

Comparables

Valuation

Metric
600329
000908
600422
Price/Earnings (Normalized)
28.2428.32
Price/Book Value
3.962.07
Price/Sales
3.086.601.47
Price/Cash Flow
27.5614.27
Price/Earnings
600329
000908
600422

Financial Strength

Metric
600329
000908
600422
Quick Ratio
1.230.111.38
Current Ratio
1.560.171.88
Interest Coverage
28.10−4.3333.20
Quick Ratio
600329
000908
600422

Profitability

Metric
600329
000908
600422
Return on Assets (Normalized)
8.07%−22.46%3.33%
Return on Equity (Normalized)
13.65%−1,863.72%6.05%
Return on Invested Capital (Normalized)
12.15%−42.67%5.18%
Return on Assets
600329
000908
600422

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
CmwjjmxpHlsr$88.3 Bil
Merck KGaA ADR
MKKGY
BfcpffdkwYxnvrv$78.0 Bil
Haleon PLC ADR
HLN
NmpphtjGbjb$48.4 Bil
Viatris Inc
VTRS
DyvztjhWcwry$13.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
NlcbgyyzvXwyt$13.5 Bil
Catalent Inc
CTLT
BwxssdlxThwdgxl$10.9 Bil
Prestige Consumer Healthcare Inc
PBH
MylhmtsWxlzmw$3.5 Bil
Perrigo Co PLC
PRGO
JbblkwptNhm$3.5 Bil
Green Thumb Industries Inc
GTBIF
CqdwqxwpvfFmwh$2.5 Bil
Curaleaf Holdings Inc
CURLF
VmkqfvgfKmbt$2.3 Bil

Sponsor Center